Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hugh Cole Insider Profile
4 Followers
Hugh Cole, SVP, Chief Business Officer at Ariad, holds 61.41K shares in Jounce Therapeutics (Ticker: JNCE), holds 0.00 shares in Ariad (Ticker: ARIA), holds ― shares in Catabasis Pharmaceuticals (Ticker: CATB). Most recently, Hugh Cole Sold ― shares of Jounce Therapeutics on Aug 18, 2020 for an estimated value of 10.28K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-27.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hugh Cole holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 10, 2020 - Jan 10, 2021
Return:+2.10%
The most profitable trade made by Hugh Cole
Hugh Cole's Trading History
Ariad
Feb 16, 2017
―
Uninformative Sell
―
$0.00
Jounce Therapeutics
Aug 18, 2020
CBO
Informative Sell
10.28K
$446.44K
Catabasis Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Hugh Cole's performance on stock
You May Also Like
Hugh Cole insider profile FAQ
What is the percentage of profitable transactions made by Hugh Cole?
The percentage of profitable transactions made by Hugh Cole is 25%.
What is the average return per transaction made by Hugh Cole?
The average return per transaction made by Hugh Cole is -27.00%.
What stocks does Hugh Cole hold?
Hugh Cole holds: ARIA, JNCE, CATB stocks.
What was Hugh Cole’s latest transaction?
Hugh Cole latest transaction was an Informative Sell of $10.28K.
What was Hugh Cole's most profitable transaction?
Hugh Cole’s most profitable transaction was an Informative Sell of JNCE stock on January 10, 2020. The return on the trade was 2.10%.
What is Hugh Cole's role in Ariad?
Hugh Cole's role in Ariad is SVP, Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.